Genetic Analysis AS (8V8.F)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ronny Hermansen MSc | Chief Executive Officer | 170.8k | -- | 1963 |
| Mr. Eilert Aamodt | Chief Financial Officer | -- | -- | -- |
| Mr. Lars Tiller | Head of Operations | -- | -- | -- |
| Ms. Christina Casen | Senior Vice President of Clinical & Medical Affairs | -- | -- | -- |
| Ms. Kari Furu | Head of Commercial | -- | -- | -- |
Genetic Analysis AS
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 21
Description
Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market. It offers GA-map Dysbiosis Test Lx, a molecular assay for profiling the gut microbiota to identify and characterize dysbiosis for treating patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease, diabetes type 2, gut disorder, lifestyle diseases, and leaky-gut syndrome; GA-map COVID-19 Fecal Test Kit, a qualitative real time standardized PCR test for the detection of the 2019 novel coronavirus RNA in stool samples; GA-map Dysbiosis Test reagent kit, a CE-IVD documented test, which is a software that performs QC on the run file, calculates the dysbiosis index score and abundance table, and converts sample result into reports; and GA-map Covid fecal test reagent kit, a CE-IVD documented test to detect SARS-CoV-2 in fecal samples. The company was founded in 2008 and is headquartered in Oslo, Norway.
Corporate Governance
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available